Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

765 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The addition of bendamustine to brentuximab vedotin leads to improved rates of complete metabolic remission in children, adolescents and young adults with relapsed and refractory classical Hodgkin lymphoma: a retrospective single-centre series.
McMillan A, O'Neill AT, Townsend W, Lambert J, Virchis A, Shah R, Menezes L, Humphries P, Von Both K, Grandage V, Carpenter B, Hough R, Ardeshna KM, Daw S. McMillan A, et al. Br J Haematol. 2021 Feb;192(3):e84-e87. doi: 10.1111/bjh.17274. Epub 2021 Jan 10. Br J Haematol. 2021. PMID: 33426648 No abstract available.
Ibrutinib for mantle cell lymphoma at first relapse: a United Kingdom real-world analysis of outcomes in 211 patients.
McCulloch R, Lewis D, Crosbie N, Eyre TA, Bolam S, Arasaretnam A, Creasey T, Goradia H, McMillan A, Dawi S, Harrison S, Miles O, Robinson A, Dutton D, Wilson MR, McKay P, Follows G, Phillips N, Patmore R, Lambert J, Bishton M, Osborne W, Johnston R, Kirkwood AA, Rule S. McCulloch R, et al. Among authors: mcmillan a. Br J Haematol. 2021 Apr;193(2):290-298. doi: 10.1111/bjh.17363. Epub 2021 Feb 23. Br J Haematol. 2021. PMID: 33620106 Free article.
Daratumumab, bortezomib and dexamethasone at first relapse for patients with multiple myeloma: A real-world multicentre UK retrospective analysis.
McMillan A, Basu S, Karunanithi K, Parkins E, Lau EYM, Cook G, Parrish C, Al-Kaisi F, Pratt G, Shafeek S, Jenkins S, Memon D, Bygrave C, Papanikolaou X, Maisel T, Hassan S, Moosai S, Chander G, Rakesh P, Kishore B, Karim F, Talbot G, Wandroo F, Yong K, Popat R. McMillan A, et al. Br J Haematol. 2023 May;201(4):682-689. doi: 10.1111/bjh.18703. Epub 2023 Feb 23. Br J Haematol. 2023. PMID: 36822820
Haematopoietic stem cell mobilisation followed by high-dose chemotherapy and autologous stem cell transplantation for patients with sickle cell disease and myeloma.
Asher S, Shah R, Ings S, Horder J, Newrick F, Nesr G, Kesse Adu R, Streetly M, Trompeter S, Lee L, Wisniowski B, Mahmood S, Xu K, Papanikalaou X, McMillan A, Popat R, Yong K, Sive J, Kyriakou C, Rabin N. Asher S, et al. Among authors: mcmillan a. Br J Haematol. 2023 Sep;202(6):1224-1227. doi: 10.1111/bjh.18990. Epub 2023 Jul 24. Br J Haematol. 2023. PMID: 37488061 No abstract available.
Serological response to the BNT162b2 mRNA or ChAdOx1 nCoV-19 COVID-19 vaccine after first and second doses in patients with plasma cell disorders: influence of host and disease factors.
Chan WY, Howells L, Wilson W, Sanchez E, Ainley L, Chavda SJ, Dowling E, Correia N, Lecat CSY, McMillan A, Wisniowski B, Mahmood S, Papanikolaou X, Lee L, Sive J, Kyriakou C, Wechalekar A, Popat R, Rabin N, Nastouli E, Yong KL, Xu K. Chan WY, et al. Among authors: mcmillan a. Br J Haematol. 2022 Feb;196(3):e21-e26. doi: 10.1111/bjh.17864. Epub 2021 Oct 10. Br J Haematol. 2022. PMID: 34632575 Free PMC article. No abstract available.
Outcomes of melphalan 140 mg/m2 followed by autologous stem cell transplantation in multiple myeloma patients with co-morbidities: Single-centre experience.
Melotti D, Asher S, Troy-Barnes E, Nesr G, Wilson W, Camilleri M, Popat R, Xu K, Rabin N, Sive J, Papanikolaou X, Lee L, McMillan A, Yong K, Kyriakou C. Melotti D, et al. Among authors: mcmillan a. EJHaem. 2024 Aug 19;5(5):1102-1106. doi: 10.1002/jha2.977. eCollection 2024 Oct. EJHaem. 2024. PMID: 39415903 Free PMC article.
Antibody-drug conjugates for multiple myeloma.
McMillan A, Warcel D, Popat R. McMillan A, et al. Expert Opin Biol Ther. 2021 Jul;21(7):889-901. doi: 10.1080/14712598.2020.1802422. Epub 2020 Aug 12. Expert Opin Biol Ther. 2021. PMID: 32729730 Review.
765 results